NYSEAMERICAN:APHB - AmpliPhi Biosciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.21 -0.01 (-0.82 %)
(As of 05/27/2018 05:51 AM ET)
Previous Close$1.21
Today's Range$1.14 - $1.25
52-Week Range$0.67 - $2.05
Volume143,590 shs
Average Volume517,687 shs
Market Capitalization$21.87 million
P/E RatioN/A
Dividend YieldN/A
Beta2.76

About AmpliPhi Biosciences (NYSEAMERICAN:APHB)

AmpliPhi Biosciences logoAmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus infections; and AB-PA01 for the treatment of pseudomonas aeruginosa infections. AmpliPhi Biosciences Corporation has a collaboration agreement and a license agreement with the University of Leicester; and a collaboration agreement with the Western Sydney Local Health District and the Westmead Institute for Medical Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.

Receive APHB News and Ratings via Email

Sign-up to receive the latest news and ratings for APHB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:APHB
CUSIPN/A
Phone+1-804-8272524

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-2,050.00%
Return on Equity-31.85%
Return on Assets-21.63%

Miscellaneous

EmployeesN/A
Outstanding Shares16,460,000

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Frequently Asked Questions

What is AmpliPhi Biosciences' stock symbol?

AmpliPhi Biosciences trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "APHB."

How were AmpliPhi Biosciences' earnings last quarter?

AmpliPhi Biosciences (NYSEAMERICAN:APHB) posted its earnings results on Wednesday, March, 14th. The biotechnology company reported ($0.25) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.36) by $0.11. The biotechnology company had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.03 million. AmpliPhi Biosciences had a negative net margin of 2,050.00% and a negative return on equity of 31.85%. View AmpliPhi Biosciences' Earnings History.

When is AmpliPhi Biosciences' next earnings date?

AmpliPhi Biosciences is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for AmpliPhi Biosciences.

What price target have analysts set for APHB?

1 brokers have issued 12 month price targets for AmpliPhi Biosciences' shares. Their predictions range from $6.00 to $6.00. On average, they anticipate AmpliPhi Biosciences' share price to reach $6.00 in the next twelve months. View Analyst Ratings for AmpliPhi Biosciences.

Are investors shorting AmpliPhi Biosciences?

AmpliPhi Biosciences saw a drop in short interest in May. As of May 15th, there was short interest totalling 858,583 shares, a drop of 7.7% from the April 30th total of 929,998 shares. Based on an average daily volume of 108,394 shares, the days-to-cover ratio is presently 7.9 days. Currently, 5.5% of the company's stock are sold short.

Who are some of AmpliPhi Biosciences' key competitors?

Who are AmpliPhi Biosciences' key executives?

AmpliPhi Biosciences' management team includes the folowing people:
  • Dr. Paul C. Grint, Chief Exec. Officer & Director (Age 60)
  • Mr. Steven R. Martin, Sr. VP & CFO (Age 57)
  • Dr. Igor P. Bilinsky Ph.D., Sr. VP & COO (Age 45)
  • Mr. Michael Scott Salka, Consultant (Age 56)
  • Dr. Alexander Gaidamaka Ph.D., D.V.M, VP of Chemistry, Manufacturing and Control

Has AmpliPhi Biosciences been receiving favorable news coverage?

News coverage about APHB stock has been trending somewhat positive on Sunday, Accern Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AmpliPhi Biosciences earned a media sentiment score of 0.14 on Accern's scale. They also assigned headlines about the biotechnology company an impact score of 45.43 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are AmpliPhi Biosciences' major shareholders?

AmpliPhi Biosciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include SABBY MANAGEMENT, LLC (7.78%) and Sabby Management LLC (5.05%). Company insiders that own AmpliPhi Biosciences stock include Jeremy Curnock Cook and Randal J Kirk. View Institutional Ownership Trends for AmpliPhi Biosciences.

Which institutional investors are buying AmpliPhi Biosciences stock?

APHB stock was acquired by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for AmpliPhi Biosciences.

How do I buy shares of AmpliPhi Biosciences?

Shares of APHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AmpliPhi Biosciences' stock price today?

One share of APHB stock can currently be purchased for approximately $1.21.

How big of a company is AmpliPhi Biosciences?

AmpliPhi Biosciences has a market capitalization of $21.87 million.

How can I contact AmpliPhi Biosciences?

AmpliPhi Biosciences' mailing address is 3579 Valley Centre Drive, SAN DIEGO, CA 92130, United States. The biotechnology company can be reached via phone at +1-804-8272524.


MarketBeat Community Rating for AmpliPhi Biosciences (APHB)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about AmpliPhi Biosciences and other stocks. Vote "Outperform" if you believe APHB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for AmpliPhi Biosciences in the last 12 months. Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 395.87%. The high price target for APHB is $6.00 and the low price target for APHB is $6.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.00$6.00$6.00$7.50
Price Target Upside: 395.87% upside282.17% upside450.46% upside772.09% upside

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Consensus Price Target History

Price Target History for AmpliPhi Biosciences (NYSEAMERICAN:APHB)

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/16/2018HC WainwrightSet Price TargetBuy$6.00View Rating Details
1/24/2017Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 5/27/2016 forward)

Earnings

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Earnings History and Estimates Chart

Earnings by Quarter for AmpliPhi Biosciences (NYSEAMERICAN:APHB)

AmpliPhi Biosciences (NYSEAMERICAN APHB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2018        
5/15/2018Q1 2018($0.19)($0.24)$0.10 millionViewListenView Earnings Details
3/14/2018Q4 2017($0.36)($0.25)$0.03 million$0.02 millionViewN/AView Earnings Details
11/14/2017Q3 2017($0.46)($0.09)$0.03 million$0.04 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.80)($0.78)$0.03 millionViewN/AView Earnings Details
5/15/2017Q1 2017($8.20)($1.94)$0.10 million$0.03 millionViewN/AView Earnings Details
3/27/2017Q4 2016($3.30)($3.20)$0.10 million$0.02 millionViewN/AView Earnings Details
11/10/2016Q3 2016($3.80)($3.20)$0.10 million$0.03 millionViewN/AView Earnings Details
8/15/2016Q216($0.66)($0.78)$0.10 million$0.10 millionViewListenView Earnings Details
5/12/2016Q116($0.68)($0.82)$0.11 million$0.11 millionViewN/AView Earnings Details
3/30/2016Q415($0.40)($0.43)$0.12 million$0.13 millionViewN/AView Earnings Details
11/16/2015Q3 2015($2.00)($3.00)$0.10 million$0.14 millionViewN/AView Earnings Details
8/13/2015Q2 2015($7.50)($5.70)$0.10 millionViewN/AView Earnings Details
5/15/2015Q1 2015($5.00)($5.00)$0.10 millionViewN/AView Earnings Details
4/15/2015Q4 2014($5.00)($5.00)$0.10 millionViewN/AView Earnings Details
11/18/2014($0.02)$0.06ViewN/AView Earnings Details
9/24/2014($0.02)($0.01)ViewN/AView Earnings Details
9/12/2014Q2 2014($10.00)($5.00)$0.31 millionViewN/AView Earnings Details
5/20/2014Q1 2014($10.00)($30.00)ViewN/AView Earnings Details
6/1/2010Q4 2009$42.50ViewN/AView Earnings Details
11/16/2009Q3 2009$16.00ViewN/AView Earnings Details
8/12/2009Q2 2009$345.50ViewN/AView Earnings Details
5/7/2009Q1 2009($35.50)ViewN/AView Earnings Details
3/31/2009Q4 2008($64.00)ViewN/AView Earnings Details
8/6/2008Q2 2008($85.00)($95.50)ViewN/AView Earnings Details
5/7/2008Q1 2008($150.00)($81.00)ViewN/AView Earnings Details
3/25/2008Q4 2007($94.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

AmpliPhi Biosciences (NYSEAMERICAN APHB) Insider Trading and Institutional Ownership History

Insider Trading History for AmpliPhi Biosciences (NYSEAMERICAN:APHB)
Insider Trading History for AmpliPhi Biosciences (NYSEAMERICAN:APHB)

AmpliPhi Biosciences (NYSEAMERICAN APHB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2018Jeremy Curnock CookDirectorBuy354,315$1.54$545,645.10330View SEC Filing  
12/29/2016Randal J KirkMajor ShareholderSell177,020$0.48$84,969.60View SEC Filing  
4/8/2016Jeremy Curnock CookDirectorBuy239,753$2.36$565,817.08View SEC Filing  
10/6/2015Louis DrapeauDirectorBuy10,000$4.39$43,900.0010,000View SEC Filing  
10/5/2015Michael Scott SalkaCEOBuy4,200$4.75$19,950.004,200View SEC Filing  
10/5/2015Wendy S JohnsonInsiderBuy1,000$4.43$4,430.001,000View SEC Filing  
3/16/2015Randal J KirkMajor ShareholderBuy13,939,392$0.17$2,369,696.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AmpliPhi Biosciences (NYSEAMERICAN APHB) News Headlines

Source:
DateHeadline
Did AmpliPhi Biosciences Corporation’s (NYSEMKT:APHB) Earnings Growth Outperform The Industry?Did AmpliPhi Biosciences Corporation’s (NYSEMKT:APHB) Earnings Growth Outperform The Industry?
finance.yahoo.com - May 25 at 5:53 PM
AmpliPhi Biosciences (APHB) Short Interest UpdateAmpliPhi Biosciences (APHB) Short Interest Update
www.americanbankingnews.com - May 25 at 2:03 AM
Reader Inquiry: Is A Run-Up In The Cards For AmpliPhi BioSciences?Reader Inquiry: Is A Run-Up In The Cards For AmpliPhi BioSciences?
seekingalpha.com - May 21 at 8:15 AM
Zacks Investment Research Comments on AmpliPhi Biosciences FY2018 Earnings (APHB)Zacks Investment Research Comments on AmpliPhi Biosciences' FY2018 Earnings (APHB)
www.americanbankingnews.com - May 21 at 1:26 AM
World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018
www.businesswire.com - May 19 at 8:10 AM
AmpliPhi Biosciences to Present at 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018AmpliPhi Biosciences to Present at 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018
finance.yahoo.com - May 18 at 8:39 AM
APHB: Case Study on AB-PA01 Presented at ISHLT Annual MeetingAPHB: Case Study on AB-PA01 Presented at ISHLT Annual Meeting
finance.yahoo.com - May 17 at 6:41 PM
AmpliPhi Biosciences (APHB) Given a $6.00 Price Target at HC WainwrightAmpliPhi Biosciences (APHB) Given a $6.00 Price Target at HC Wainwright
www.americanbankingnews.com - May 16 at 3:41 PM
AmpliPhi Biosciences (APHB) Misses Q1 EPS by 5cAmpliPhi Biosciences (APHB) Misses Q1 EPS by 5c
www.streetinsider.com - May 16 at 8:19 AM
AmpliPhi Biosciences (APHB) CEO Paul Grint on Q1 2018 Results - Earnings Call TranscriptAmpliPhi Biosciences' (APHB) CEO Paul Grint on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 8:19 AM
AmpliPhi Biosciences (APHB) Issues Quarterly  Earnings ResultsAmpliPhi Biosciences (APHB) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 15 at 9:32 PM
AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business HighlightsAmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights
finance.yahoo.com - May 15 at 5:49 PM
AmpliPhi Biosciences Corporation’s (NYSEMKT:APHB) Shift From Loss To ProfitAmpliPhi Biosciences Corporation’s (NYSEMKT:APHB) Shift From Loss To Profit
finance.yahoo.com - May 14 at 5:20 PM
Free Technical Insights on Aimmune Therapeutics and Three More Biotech StocksFree Technical Insights on Aimmune Therapeutics and Three More Biotech Stocks
finance.yahoo.com - May 10 at 8:24 AM
AmpliPhi Biosciences (APHB) Short Interest Down 9.3% in AprilAmpliPhi Biosciences (APHB) Short Interest Down 9.3% in April
www.americanbankingnews.com - May 10 at 1:18 AM
AmpliPhi Biosciences (APHB) Scheduled to Post Quarterly Earnings on MondayAmpliPhi Biosciences (APHB) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - May 7 at 3:28 AM
AmpliPhi Biosciences Will Utilize NIAID Preclinical Services to Advance Development of Its Targeted Therapeutic Candidate for the Treatment of Resistant Staphylococcus AureusAmpliPhi Biosciences Will Utilize NIAID Preclinical Services to Advance Development of Its Targeted Therapeutic Candidate for the Treatment of Resistant Staphylococcus Aureus
finance.yahoo.com - May 3 at 5:25 PM
AmpliPhi Biosciences (APHB) Sees Large Decline in Short InterestAmpliPhi Biosciences (APHB) Sees Large Decline in Short Interest
www.americanbankingnews.com - April 25 at 1:46 AM
AmpliPhi Biosciences (APHB) Short Interest Down 9.5% in MarchAmpliPhi Biosciences (APHB) Short Interest Down 9.5% in March
www.americanbankingnews.com - April 11 at 2:04 AM
AmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Study at ISHLT Annual MeetingAmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Study at ISHLT Annual Meeting
finance.yahoo.com - April 3 at 8:23 AM
HC Wainwright Increases AmpliPhi Biosciences (APHB) Price Target to $6.00HC Wainwright Increases AmpliPhi Biosciences (APHB) Price Target to $6.00
www.americanbankingnews.com - March 27 at 6:48 PM
Tuesday 3/27 Insider Buying Report: FLL, APHBTuesday 3/27 Insider Buying Report: FLL, APHB
www.nasdaq.com - March 27 at 5:14 PM
Form 4 AmpliPhi Biosciences For: Jun 21 Filed by: COOK JEREMY CURNOCKForm 4 AmpliPhi Biosciences For: Jun 21 Filed by: COOK JEREMY CURNOCK
www.streetinsider.com - March 27 at 5:14 PM
AmpliPhi Biosciences (APHB) Director Buys $345,328.40 in StockAmpliPhi Biosciences (APHB) Director Buys $345,328.40 in Stock
www.americanbankingnews.com - March 26 at 10:26 PM
AmpliPhi Biosciences (APHB) Director Jeremy Curnock Cook Purchases 354,315 SharesAmpliPhi Biosciences (APHB) Director Jeremy Curnock Cook Purchases 354,315 Shares
www.americanbankingnews.com - March 26 at 10:08 PM
Short Interest in AmpliPhi Biosciences (APHB) Increases By 16.7%Short Interest in AmpliPhi Biosciences (APHB) Increases By 16.7%
www.americanbankingnews.com - March 26 at 6:54 PM
APHB: Expecting to Meet with FDA in mid-2018 to Determine Regulatory Path ForwardAPHB: Expecting to Meet with FDA in mid-2018 to Determine Regulatory Path Forward
finance.yahoo.com - March 26 at 5:18 PM
AmpliPhi Biosciences Announces Closing of Registered Direct Offering of Common Stock - Business Wire (press release)AmpliPhi Biosciences Announces Closing of Registered Direct Offering of Common Stock - Business Wire (press release)
www.businesswire.com - March 23 at 8:18 AM
AmpliPhi Biosciences Announces Closing of Registered Direct Offering of Common StockAmpliPhi Biosciences Announces Closing of Registered Direct Offering of Common Stock
finance.yahoo.com - March 22 at 5:36 PM
AmpliPhi Bio commences direct stock offering at $1.10; shares down 16% premarketAmpliPhi Bio commences direct stock offering at $1.10; shares down 16% premarket
seekingalpha.com - March 20 at 5:18 PM
AmpliPhi Biosciences (APHB) Announces Registered Direct Offering of Common StockAmpliPhi Biosciences (APHB) Announces Registered Direct Offering of Common Stock
www.streetinsider.com - March 20 at 5:18 PM
AmpliPhi to Collaborate with Western Sydney Local Health District and Westmead Institute for Medical Research on ... - Business Wire (press release)AmpliPhi to Collaborate with Western Sydney Local Health District and Westmead Institute for Medical Research on ... - Business Wire (press release)
www.businesswire.com - March 20 at 8:27 AM
AmpliPhi Biosciences (APHB) Announces Registered Direct Offering of Common Stock - StreetInsider.comAmpliPhi Biosciences (APHB) Announces Registered Direct Offering of Common Stock - StreetInsider.com
www.streetinsider.com - March 20 at 8:27 AM
AmpliPhi Biosciences Announces Registered Direct Offering of Common StockAmpliPhi Biosciences Announces Registered Direct Offering of Common Stock
finance.yahoo.com - March 20 at 8:27 AM
AmpliPhi Bio expands compassionate use for AB-SA01 and AB-PA01 in AustraliaAmpliPhi Bio expands compassionate use for AB-SA01 and AB-PA01 in Australia
seekingalpha.com - March 19 at 5:18 PM
AmpliPhi to Collaborate with Western Sydney Local Health District and Westmead Institute for Medical Research on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01AmpliPhi to Collaborate with Western Sydney Local Health District and Westmead Institute for Medical Research on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01
finance.yahoo.com - March 19 at 5:18 PM
AmpliPhi Biosciences beats by $0.11, misses on revenueAmpliPhi Biosciences beats by $0.11, misses on revenue
seekingalpha.com - March 16 at 6:30 PM
AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights - Business Wire (press release)AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights - Business Wire (press release)
www.businesswire.com - March 16 at 8:19 AM
HC Wainwright Analysts Give Ampliphi Biosciences (APHB) a $6.00 Price TargetHC Wainwright Analysts Give Ampliphi Biosciences (APHB) a $6.00 Price Target
www.americanbankingnews.com - March 15 at 4:54 PM
AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business HighlightsAmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
finance.yahoo.com - March 14 at 7:07 PM
AmpliPhi to collaborate with the U.S. Department of Veterans Affairs on expanded access for AB-SA01 and AB-PA01AmpliPhi to collaborate with the U.S. Department of Veterans Affairs on expanded access for AB-SA01 and AB-PA01
seekingalpha.com - March 13 at 7:17 PM
AmpliPhi to Collaborate with the US Department of Veterans Affairs on Expanded Access for Investigational ... - Business Wire (press release)AmpliPhi to Collaborate with the US Department of Veterans Affairs on Expanded Access for Investigational ... - Business Wire (press release)
www.businesswire.com - March 13 at 8:25 AM
AmpliPhi Biosciences (APHB) Reports Agreement with US Dept of Veteran Affairs to Expand Access for Investigational ... - StreetInsider.comAmpliPhi Biosciences (APHB) Reports Agreement with US Dept of Veteran Affairs to Expand Access for Investigational ... - StreetInsider.com
www.streetinsider.com - March 13 at 8:25 AM
AmpliPhi to Collaborate with the U.S. Department of Veterans Affairs on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01AmpliPhi to Collaborate with the U.S. Department of Veterans Affairs on Expanded Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01
finance.yahoo.com - March 13 at 8:25 AM
Wired News – AmpliPhi Biosciences Presents Pre-Clinical Data Validating AB-PA01’s Efficacy in Reducing Biofilm in Pseudomonas Aeruginosa InfectionsWired News – AmpliPhi Biosciences Presents Pre-Clinical Data Validating AB-PA01’s Efficacy in Reducing Biofilm in Pseudomonas Aeruginosa Infections
finance.yahoo.com - March 13 at 8:25 AM
Ampliphi Biosciences Corp (APHB) Short Interest Up 9.7% in FebruaryAmpliphi Biosciences Corp (APHB) Short Interest Up 9.7% in February
www.americanbankingnews.com - March 9 at 6:22 PM
AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces Biofilm in ... - Business Wire (press release)AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces Biofilm in ... - Business Wire (press release)
www.businesswire.com - March 9 at 8:20 AM
AmpliPhi Biosciences (APHB) Announces Presentation of Preclinical Data on AB-PA01 - StreetInsider.comAmpliPhi Biosciences (APHB) Announces Presentation of Preclinical Data on AB-PA01 - StreetInsider.com
www.streetinsider.com - March 9 at 8:20 AM
AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces Biofilm in Pseudomonas aeruginosa In Vivo ModelAmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces Biofilm in Pseudomonas aeruginosa In Vivo Model
finance.yahoo.com - March 9 at 8:20 AM
Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Ampio Pharmaceuticals, AmpliPhi Biosciences ... - PR Newswire (press release)Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Ampio Pharmaceuticals, AmpliPhi Biosciences ... - PR Newswire (press release)
www.prnewswire.com - March 6 at 8:15 AM

SEC Filings

AmpliPhi Biosciences (NYSEAMERICAN:APHB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AmpliPhi Biosciences (NYSEAMERICAN:APHB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AmpliPhi Biosciences (NYSEAMERICAN APHB) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.